Public-Private Partnership Builds Africa’s First Multi-Vaccine Production Plant
European investors have announced their partnership with South African biopharmaceutical company The Biovac Institute in building Africa’s first end-to-end multi-vaccine manufacturing facility in South Africa. Biovac projects to annually produce tens of millions of doses of vaccines for cholera, polio, and pneumonia. The plant will be the continent’s first end-to-end vaccine manufacturing plant, and the […]